Epidemiology
Etiology
- Primary hypothyroidism: insufficient thyroid hormone production
- Hashimoto thyroiditis
- The most common cause of hypothyroidism in iodine-sufficient regions
- Associated with HLA-DR3 and other autoimmune diseases (e.g., vitiligo, pernicious anemia, type 1 diabetes mellitus, and systemic lupus erythematosus)
- Postpartum thyroiditis (subacute lymphocytic thyroiditis)
- De Quervain thyroiditis (subacute granulomatous thyroiditis): often subsequent to a flu-like illness
- Iatrogenic: e.g., post thyroidectomy, radioiodine therapy, antithyroid medication (e.g., amiodarone, lithium)
- Nutritional (insufficient intake of iodine): the most common cause of hypothyroidism worldwide, particularly in iodine-deficient regions
- Riedel thyroiditis: occurs in IgG4-related systemic disease
- Wolff-Chaikoff effect
- Thyroid dysplasia: a disorder of embryologic development characterized by abnormal development and/or location of thyroid tissue (e.g., lingual thyroid)
- Hashimoto thyroiditis
- Secondary hypothyroidism: pituitary disorders (e.g., pituitary adenoma) → TSH deficiency
- Tertiary hypothyroidism: hypothalamic disorders → TRH deficiency
Pathophysiology
Clinical features
- Symptoms related to decreased metabolic rate
- Hair loss (Queen Anne sign), brittle nails, and cold, dry skin
- Symptoms related to generalized myxedema
- Hoarse voice, difficulty articulating words
- Symptoms of hyperprolactinemia
- Abnormal menstrual cycle (esp. secondary amenorrhea or menorrhagia)
- Galactorrhea
- Decreased libido, erectile dysfunction, delayed ejaculation, and infertility in men
Diagnostics
Treatment
Hypothyroidism is treated with lifelong hormone substitution.
- Levothyroxine: synthetic form of T4
- First-line choice for the treatment of hypothyroidism
- Peripherally converted to T3 (biologically active metabolite) and rT3 (biologically inactive metabolite)
- Liothyronine: synthetic form of T3
- Part of the treatment for myxedema coma
- Not recommended as monotherapy or in combination with levothyroxine for the long-term treatment of hypothyroidism
- Liothyronine has a short half-life and requires three to four daily doses, making it less suitable than levothyroxine for the ongoing treatment of hypothyroidism.
Mnemonic
T4 (levothyroxine; levo = 4 letters) or T3 (liothyronine; lio = 3 letters)
Congenital hypothyroidism
Clinical features
- Umbilical hernia
- Prolonged neonatal jaundice
- Most commonly, unconjugated hyperbilirubinemia
- Primarily due to decreased UDP-glucuronosyltransferase activity
- Most commonly, unconjugated hyperbilirubinemia
- Hypotonia
- Decreased activity, poor feeding, and adipsia
- Hoarse cry, macroglossia
- Cretinism: a complication of severe, untreated congenital hypothyroidism that leads to impaired development of the brain and skeleton, resulting in skeletal abnormalities (e.g., short stature and delayed fontanelle closure) and permanent intellectual disabilities
Warning
Most children with congenital hypothyroidism do not have symptoms at the time of birth because the placenta supplies the fetus with maternal thyroid hormone. For this reason, neonatal screening is vital even if children are asymptomatic. Irreversible intellectual disabilities can be avoided through early initiation of adequate therapy!
Diagnostics
- Neonatal screening to measure TSH levels 24–48 hours after birth is required by law.
- Increased TSH levels indicate congenital hypothyroidism.